MarketInOut Stock Screener Log In | Sign Up

Yungjin Pharm. Co Ltd

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Yungjin Pharm. Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization173,931 mln
Float86.96 mln
Earnings Date07/30/2025

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.49
Borderline

Relative Strength

24 / 100
Significantly lagging

Debt / Equity

0.90
Moderate leverage

Pre-Tax Margin

-3%
Barely loss-making

ROE

-6.99
Negative

Business Description

Founded in 1952 and based in Seoul, Yungjin Pharm is a South Korean subsidiary of KT&G Corporation that develops and sells a broad range of medicines and health products at home and abroad. Its portfolio covers treatments for heart conditions, respiratory issues, infections, mental health, and digestive problems, among others, as well as nutritional supplements, vitamins, minerals, and active pharmaceutical ingredients.

Key Fundamentals

EPS-34.21
ROE-6.99
RPS1,001
ROIC-1.67
ROA-2.58
Interest Cover-1.10
EBITDA, mln5,194
EV / EBITDA50.24
EV / EBIT-67.12
Revenue, mln253,003
EV / Revenue1.03

Quote Details

Last 931.00
Change 0 (0%)
Open 928.00
Volume 396,710
Turnover 369,337,024
Average Volume 274,187

Financial Ratios

Pre-Tax Profit Margin-3
Leverage Ratio2.64
Current Ratio1.47
Price / Book2.17
Price / Tangible Book2.23
Debt / Equity0.90
Price / Sales0.74

Financial Strength

Altman Z-Score1.89
Piotroski F-Score 3 / 9
Beneish M-Score-2.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.58% 24 / 100   
1 Month -9.35% 48 / 100   
2 Months -21.24% 13 / 100   
6 Months -47.9% 18 / 100   
1 Year -52.6% 12 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog